Acetylcysteine - Adherex Technologies
Alternative Names: N-acetylcysteine - adherex; NAC - AdherexLatest Information Update: 02 Oct 2021
At a glance
- Originator Oregon Health & Science University
- Class Anti-inflammatories; Antibronchitics; Antidotes; Expectorants; Reducing agents; Small molecules; Sulfur amino acids
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chemotherapy-induced damage
Most Recent Events
- 22 Oct 2003 Acetylcysteine is available for licensing
- 04 Feb 2003 Phase-I/II clinical trials in Chemotherapy induced damage (Prevention)/Chemoprotection in USA (unspecified route)